FDA-Device2026-09-09Class IIPROCESSING DEFECT

Diagnostica Stago STA Staclot Protein S reagent recalled for QC drift

OTHERNationwide distributionMedical devices

What this means

Diagnostica Stago identified a positive drift in quality control (QC) values in one lot of STA Staclot Protein S reagent within the product's stated 4-hour stability period. This drift could affect the accuracy of test results performed during that window. The issue affects reagent Lot 273074 distributed nationwide.

  • Check your facility's inventory for STA Staclot Protein S Lot 273074 (Exp 3/31/2027).
  • Contact Diagnostica Stago or your supplier for instructions on return or replacement.
  • Review any patient results generated with this lot and follow your laboratory's quality protocol.
The agency's original wording
Hazard

A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

Intended for
All ages
Illnesses reported
None reported
Sold states
US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR.
Affected count
5220 units
Manufactured in
5 Century Dr, N/A, Parsippany, NJ, United States
Products
STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-3047-2026

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime